Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 29474-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- WEE1 antibody
- Antibody type
- Polyclonal
- Description
- WEE1 antibody (Cat. #29474-1-AP) is a rabbit polyclonal antibody that shows reactivity with Human, mouse and has been validated for the following applications: WB, ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references DIS3L2 ribonuclease degrades terminal-uridylated RNA to ensure oocyte maturation and female fertility.
miR-138-5p Inhibits the Growth and Invasion of Glioma Cells by Regulating WEE1.
Venetoclax enhances DNA damage induced by XPO1 inhibitors: A novel mechanism underlying the synergistic antileukaemic effect in acute myeloid leukaemia.
High-dose zearalenone exposure disturbs G2/M transition during mouse oocyte maturation.
Wu D, Pedroza M, Chang J, Dean J
Nucleic acids research 2023 Apr 24;51(7):3078-3093
Nucleic acids research 2023 Apr 24;51(7):3078-3093
miR-138-5p Inhibits the Growth and Invasion of Glioma Cells by Regulating WEE1.
Gong J, Tang Z, Yu Z, Deng Z, Liu Y, Ren N, Wang L, He Z
Analytical cellular pathology (Amsterdam) 2022;2022:7809882
Analytical cellular pathology (Amsterdam) 2022;2022:7809882
Venetoclax enhances DNA damage induced by XPO1 inhibitors: A novel mechanism underlying the synergistic antileukaemic effect in acute myeloid leukaemia.
Yu H, Wu S, Liu S, Li X, Gai Y, Lin H, Wang Y, Edwards H, Ge Y, Wang G
Journal of cellular and molecular medicine 2022 May;26(9):2646-2657
Journal of cellular and molecular medicine 2022 May;26(9):2646-2657
High-dose zearalenone exposure disturbs G2/M transition during mouse oocyte maturation.
Ji YM, Zhang KH, Pan ZN, Ju JQ, Zhang HL, Liu JC, Wang Y, Sun SC
Reproductive toxicology (Elmsford, N.Y.) 2022 Jun;110:172-179
Reproductive toxicology (Elmsford, N.Y.) 2022 Jun;110:172-179
No comments: Submit comment
No validations: Submit validation data